Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Sanofi    SAN   FR0000120578


Real-time Quote. Real-time Tradegate - 10/27 02:49:33 pm
69.085 EUR   +1.43%
07:02a SANOFI : Pasteur, Fiocruz, and WRAIR Agree to Collaborate on Zika Va..
10/25 SANOFI : - Sanofi : signs landmark agreement to combat antimicrobial..
10/25 GLOBAL DIABETIC : Nono Nordisk, Eli Llly, Sanofi, Merk, Tonghua Dong..
News SummaryMost relevantAll newsSector news 

SANOFI : Former Sanofi employees convicted of bribery in Germany

share with twitter share with LinkedIn share with facebook
share via e-mail
03/03/2014 | 07:24pm CEST

A German court convicted two former employees of Sanofi-Aventis on bribery charges 10 months ago and imposed a fine on the French drugmaker last year, prosecutors said on Monday following a newspaper report.

News of the 28 million euro ($39 million) fine coincides with heightened scrutiny of Big Pharma's sales practices after a bribery scandal in China hit business there last year.

Further investigations are ongoing, a spokesman for prosecutors in the northern German town of Verden said, confirming a report by German daily newspaper Frankfurter Allgemeine Zeitung, but they declined to say whether these were related to Sanofi or to its employees.

The spokesman said an investigation of the former Sanofi employees found that they had made illicit payments to a consultancy advising one of the drugmaker's clients between 2007 and 2010 to win more orders from the client, a pharmaceuticals dealer.

"Sanofi was unfairly given preference because of this," he said.

He declined to provide details on who the client was or which markets it operated in. He also did not name the former Sanofi employees or the consultant.

A court in the town of Winsen handed the two former employees of Sanofi suspended sentences for bribery in business transactions in May 2013, the spokesman said. They both worked with Sanofi's sales force and were not senior managers.

The Winsen court also ordered that punishment be meted out to the owner of the consultancy, but that judgment was not yet final due to a pending complaint against the ruling.

The bribery investigation has not come to light until now because the suspects were sentenced via a simplified legal process that under German law allows courts to try some crimes without a courtroom trial.

The court's ruling also resulted in a 28 million euro fine for Sanofi. A spokeswoman for Sanofi-Aventis Deutschland GmbH confirmed the company had to pay that sum in connection with the case against the two former employees.

"For Sanofi the matter is closed," the spokeswoman said, referring to the Winsen court's rulings. She added the company had cooperated with authorities during the investigation and had since further tightened its compliance system.

Sanofi acquired Aventis in 2004, creating Sanofi-Aventis. In 2011, the company simplified its name to Sanofi.

(Reporting by Maria Sheahan and Frank Siebelt; Additional reporting by Natalie Huet in Paris; Writing by Marilyn Gerlach; editing by Mike Collett-White)

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on SANOFI
07:02a SANOFI : Pasteur, Fiocruz, and WRAIR Agree to Collaborate on Zika Vaccine Resear..
10/25 SANOFI : - Sanofi : signs landmark agreement to combat antimicrobial resistance
10/25 GLOBAL DIABETIC NEPHROPATHY (INSULIN : Nono Nordisk, Eli Llly, Sanofi, Merk, Ton..
10/25SANOFI SA : quaterly earnings release
10/21 SANOFI : Genzyme Assigned Patent
10/19 PROMIS NEUROSCIENCES : announces appointment of Dr. Richard Gregory to its Board..
10/18 GLOBAL MENINGOCOCCAL INFECTIONS VACC : Sanofi-Pasteur, Beijing Tiantan Biologica..
10/18 SCHNEIDER ELECTRIC : Three air france apprentices win prizes at altern'up
10/13 REGENERON PHARMACEUTICALS : and Sanofi Announce Positive Dupixent® dupilumab Pha..
10/13 SANOFI : Availability of the Pre-quarterly Results Communication
More news
Sector news : Pharmaceuticals - NEC
10/26 GLAXOSMITHKLINE : British imports of cheap medicines dry up as pound falls
10/26DJGlaxo Profit Jumps on Weaker Pound
10/26 Bayer third-quarter profit beats forecasts on pharma, pesticides
10/25DJMERCK : Profit Rises on Cancer Drugs, Vaccines
10/25DJMERCK : Revenue and Profit Rise on Cancer Drugs, Vaccines -- Update
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
06:59a WALL STREET BREAKFAST : Semiconductor Consolidation Continues
04:44a Sanofi accelerates Zika vaccine work
10/18 In Less Than A Month, Regeneron's Luck Kicks In
10/17 Tracking Ken Fisher's Fisher Asset Management Portfolio - Q3 2016 Update
10/14 WALL STREET BREAKFAST : Big Bank Earnings On Tap
Financials (€)
Sales 2016 36 665 M
EBIT 2016 9 178 M
Net income 2016 5 260 M
Debt 2016 5 715 M
Yield 2016 4,39%
P/E ratio 2016 15,37
P/E ratio 2017 14,17
EV / Sales 2016 2,55x
EV / Sales 2017 2,57x
Capitalization 87 802 M
More Financials
Duration : Period :
Sanofi Technical Analysis Chart | SAN | FR0000120578 | 4-Traders
Full-screen chart
Technical analysis trends SANOFI
Short TermMid-TermLong Term
Technical analysis
Income Statement Evolution
More Financials
Mean consensus HOLD
Number of Analysts 25
Average target price 81,3 €
Spread / Average Target 19%
Consensus details
EPS Revisions
More Estimates Revisions
Olivier Brandicourt Chief Executive Officer & Director
Serge Weinberg Chairman
Jérôme Contamine Chief Financial Officer & EVP-Finance
Elias E. Zerhouni President-Global Research & Development
Yong-Jun Liu Head-Global Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
SANOFI-13.35%95 774
JOHNSON & JOHNSON11.53%313 422
ROCHE HOLDING LTD.-17.44%196 913
PFIZER INC.0.37%196 527
NOVARTIS AG-16.42%188 199
MERCK & CO., INC.15.24%168 318
More Results